Skip to main content

Case study: Rare diseases

Case study

Data-driven physician engagement for ultra-rare diseases

Learn how Quest Diagnostics leveraged data analytics to help identify treating physicians of eligible patients for a new therapy targeting an ultra-rare and aggressive form of cancer.

 

This case study is free and can be downloaded and read at your convenience.

Quest lab stewardship services working on reducing care variation through lab analytics

Integrating advanced analytics with clinical insights

Leverage the power of advanced data analytics to overcome the challenges of commercializing therapies for ultra-rare diseases. This case study highlights how Quest Diagnostics successfully collaborated with a leading pharmaceutical company to help identify eligible patients for a groundbreaking therapy, despite the absence of a definitive diagnostic test. By utilizing sophisticated algorithms and clinical markers, Quest pinpointed physicians treating patients with subtle symptoms of the disease, resulting in 158 potential cases and 20 eligible candidates for treatment. 

This data-driven methodology not only supported physician identification but also enhanced broader commercial strategies, demonstrating the immense value of integrating analytics into therapeutic development. 

Download the full case study to discover how Quest Diagnostics can empower your efforts in ultra-rare disease therapy commercialization. 

Let's discuss collaborative opportunities to bring new treatments to patients faster. Let's talk!

770

* indicates required